Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms

The aim of our study was to obtain rutoside (RUT) inclusion complexes in β-cyclodextrin (β-CD) and in hydroxypropyl-β-cyclodextrin (HP-β-CD), in a 1:1 molar ratio, using the lyophilization method of complexation in solution. The complexes were confirmed and characterized, in comparison with the raw...

Full description

Bibliographic Details
Main Authors: Teodora Balaci, Bruno Velescu, Oana Karampelas, Adina Magdalena Musuc, George Mihai Nițulescu, Emma Adriana Ozon, Georgiana Nițulescu, Cerasela Elena Gîrd, Catalina Fița, Dumitru Lupuliasa
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Processes
Subjects:
Online Access:https://www.mdpi.com/2227-9717/9/1/26
id doaj-718e06fd6ffa4e3db0d596d6cc2afe31
record_format Article
spelling doaj-718e06fd6ffa4e3db0d596d6cc2afe312020-12-25T00:02:57ZengMDPI AGProcesses2227-97172021-12-019262610.3390/pr9010026Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage FormsTeodora Balaci0Bruno Velescu1Oana Karampelas2Adina Magdalena Musuc3George Mihai Nițulescu4Emma Adriana Ozon5Georgiana Nițulescu6Cerasela Elena Gîrd7Catalina Fița8Dumitru Lupuliasa9Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaRomanian Academy, “Ilie Murgulescu” Institute of Physical Chemistry, 202 Spl. Independentei, 060021 Bucharest, RomaniaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmacognosy, Phytochemistry, Phytotherapy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaDepartment of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, RomaniaThe aim of our study was to obtain rutoside (RUT) inclusion complexes in β-cyclodextrin (β-CD) and in hydroxypropyl-β-cyclodextrin (HP-β-CD), in a 1:1 molar ratio, using the lyophilization method of complexation in solution. The complexes were confirmed and characterized, in comparison with the raw materials and their simple physical mixtures, by SEM, DSC, and FT-IR analyses. The antioxidant activity of the compounds was assessed by using the 2,2-diphenyl-1-picryl-hydrazyl (DPPH) and 2’-azino-bis(3-ethylbenzothiazolin-6-sulfonic) acid (ABTS) radicals, determining the radical scavenging activity, and by ferric reducing antioxidant power (FRAP) assay. The results revealed superior antioxidant ability for the inclusion complexes towards rutoside alone. The inclusion complexes were used as active ingredients in formulations of immediate-release tablets. The preformulation studies were performed on the powders for direct compression obtained after mixing the active ingredients with the excipients (Avicel PH 102, Polyplasdone XL-10, magnesium stearate, and talc). The materials were assessed for particle size, flowability, compressibility, and moisture content, establishing they are suitable for a direct compression process. The tablets were characterized regarding their pharmaco-technical properties and the results proved that the formulations lead to high-quality delivery systems, showing a good mechanical resistance with a low friability, excellent disintegration times, and satisfying dissolution rate. The performances were very similar for both formulations and the physico-mechanical properties of the tablets are not influenced by type of the used cyclodextrin, but the RUT- HP-β-CD tablets presented a higher dissolution rate.https://www.mdpi.com/2227-9717/9/1/26rutosideβ-cyclodextrinhydroxypropyl-β-cyclodextrininclusion complexesantioxidant activity
collection DOAJ
language English
format Article
sources DOAJ
author Teodora Balaci
Bruno Velescu
Oana Karampelas
Adina Magdalena Musuc
George Mihai Nițulescu
Emma Adriana Ozon
Georgiana Nițulescu
Cerasela Elena Gîrd
Catalina Fița
Dumitru Lupuliasa
spellingShingle Teodora Balaci
Bruno Velescu
Oana Karampelas
Adina Magdalena Musuc
George Mihai Nițulescu
Emma Adriana Ozon
Georgiana Nițulescu
Cerasela Elena Gîrd
Catalina Fița
Dumitru Lupuliasa
Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
Processes
rutoside
β-cyclodextrin
hydroxypropyl-β-cyclodextrin
inclusion complexes
antioxidant activity
author_facet Teodora Balaci
Bruno Velescu
Oana Karampelas
Adina Magdalena Musuc
George Mihai Nițulescu
Emma Adriana Ozon
Georgiana Nițulescu
Cerasela Elena Gîrd
Catalina Fița
Dumitru Lupuliasa
author_sort Teodora Balaci
title Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
title_short Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
title_full Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
title_fullStr Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
title_full_unstemmed Physico-Chemical and Pharmaco-Technical Characterization of Inclusion Complexes Formed by Rutoside with β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Used to Develop Solid Dosage Forms
title_sort physico-chemical and pharmaco-technical characterization of inclusion complexes formed by rutoside with β-cyclodextrin and hydroxypropyl-β-cyclodextrin used to develop solid dosage forms
publisher MDPI AG
series Processes
issn 2227-9717
publishDate 2021-12-01
description The aim of our study was to obtain rutoside (RUT) inclusion complexes in β-cyclodextrin (β-CD) and in hydroxypropyl-β-cyclodextrin (HP-β-CD), in a 1:1 molar ratio, using the lyophilization method of complexation in solution. The complexes were confirmed and characterized, in comparison with the raw materials and their simple physical mixtures, by SEM, DSC, and FT-IR analyses. The antioxidant activity of the compounds was assessed by using the 2,2-diphenyl-1-picryl-hydrazyl (DPPH) and 2’-azino-bis(3-ethylbenzothiazolin-6-sulfonic) acid (ABTS) radicals, determining the radical scavenging activity, and by ferric reducing antioxidant power (FRAP) assay. The results revealed superior antioxidant ability for the inclusion complexes towards rutoside alone. The inclusion complexes were used as active ingredients in formulations of immediate-release tablets. The preformulation studies were performed on the powders for direct compression obtained after mixing the active ingredients with the excipients (Avicel PH 102, Polyplasdone XL-10, magnesium stearate, and talc). The materials were assessed for particle size, flowability, compressibility, and moisture content, establishing they are suitable for a direct compression process. The tablets were characterized regarding their pharmaco-technical properties and the results proved that the formulations lead to high-quality delivery systems, showing a good mechanical resistance with a low friability, excellent disintegration times, and satisfying dissolution rate. The performances were very similar for both formulations and the physico-mechanical properties of the tablets are not influenced by type of the used cyclodextrin, but the RUT- HP-β-CD tablets presented a higher dissolution rate.
topic rutoside
β-cyclodextrin
hydroxypropyl-β-cyclodextrin
inclusion complexes
antioxidant activity
url https://www.mdpi.com/2227-9717/9/1/26
work_keys_str_mv AT teodorabalaci physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT brunovelescu physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT oanakarampelas physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT adinamagdalenamusuc physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT georgemihainitulescu physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT emmaadrianaozon physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT georgiananitulescu physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT ceraselaelenagird physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT catalinafita physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
AT dumitrulupuliasa physicochemicalandpharmacotechnicalcharacterizationofinclusioncomplexesformedbyrutosidewithbcyclodextrinandhydroxypropylbcyclodextrinusedtodevelopsoliddosageforms
_version_ 1724371548629893120